DK0516851T3 - Fysiologisk aktiv substans, der er i stand til at gennemtrænge en biomembran - Google Patents

Fysiologisk aktiv substans, der er i stand til at gennemtrænge en biomembran

Info

Publication number
DK0516851T3
DK0516851T3 DK91905340.5T DK91905340T DK0516851T3 DK 0516851 T3 DK0516851 T3 DK 0516851T3 DK 91905340 T DK91905340 T DK 91905340T DK 0516851 T3 DK0516851 T3 DK 0516851T3
Authority
DK
Denmark
Prior art keywords
biomembrane
permeating
active substance
physiologically active
substance capable
Prior art date
Application number
DK91905340.5T
Other languages
Danish (da)
English (en)
Inventor
Kouki Kitagawa
Toru Hibi
Noriko Mizobuchi
Original Assignee
Teikoku Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teikoku Seiyaku Kk filed Critical Teikoku Seiyaku Kk
Application granted granted Critical
Publication of DK0516851T3 publication Critical patent/DK0516851T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/267—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/63—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/70—Enkephalins
    • C07K14/702—Enkephalins with at least 1 amino acid in D-form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
DK91905340.5T 1990-02-28 1991-02-27 Fysiologisk aktiv substans, der er i stand til at gennemtrænge en biomembran DK0516851T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5011690 1990-02-28

Publications (1)

Publication Number Publication Date
DK0516851T3 true DK0516851T3 (da) 1996-07-15

Family

ID=12850141

Family Applications (2)

Application Number Title Priority Date Filing Date
DK95105215T DK0668290T3 (da) 1990-02-28 1991-02-27 Fysiologisk aktiv substans, som er i stand til at gennemtrænge biomembranen
DK91905340.5T DK0516851T3 (da) 1990-02-28 1991-02-27 Fysiologisk aktiv substans, der er i stand til at gennemtrænge en biomembran

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK95105215T DK0668290T3 (da) 1990-02-28 1991-02-27 Fysiologisk aktiv substans, som er i stand til at gennemtrænge biomembranen

Country Status (5)

Country Link
EP (2) EP0668290B1 (de)
CA (1) CA2076849A1 (de)
DE (2) DE69130489T2 (de)
DK (2) DK0668290T3 (de)
WO (1) WO1991013081A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264129B1 (it) * 1993-04-09 1996-09-16 Codev S A Peptidi ad attivita' immunomodulatoria derivati da frammenti di leucochinina
US5973128A (en) * 1996-11-22 1999-10-26 The Hospital For Sick Children Research And Development Lp Glycolipid mimics and methods of use thereof
US8415354B2 (en) 2004-04-29 2013-04-09 Abbott Laboratories Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
US20100222316A1 (en) 2004-04-29 2010-09-02 Abbott Laboratories Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
US7880001B2 (en) 2004-04-29 2011-02-01 Abbott Laboratories Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
CN103242192B (zh) 2005-01-05 2016-05-04 Abbvie公司 11-β-羟甾类脱氢酶1型酶的抑制剂
US20090192198A1 (en) 2005-01-05 2009-07-30 Abbott Laboratories Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
WO2006074330A2 (en) 2005-01-05 2006-07-13 Abbott Laboratories Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
US8198331B2 (en) 2005-01-05 2012-06-12 Abbott Laboratories Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
JP5736098B2 (ja) 2007-08-21 2015-06-17 アッヴィ・インコーポレイテッド 中枢神経系障害を治療するための医薬組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1179997A1 (ru) * 1973-02-28 1985-09-23 Ордена Трудового Красного Знамени Институт Органического Синтеза Ан Латсср Средство дл лечени паркинсонизма "глудантан
JPS5143769A (en) * 1974-10-14 1976-04-14 Asahi Chemical Ind 11 beeta dd arabinofuranoshirushitoshinjudotaino seizoho
JPS5919557B2 (ja) * 1979-05-02 1984-05-07 ヤマサ醤油株式会社 Ｎ↑６−置換コルジセピン誘導体およびその製造法
US4273704A (en) * 1979-12-03 1981-06-16 G. D. Searle & Co. N-Adamantane-substituted tetrapeptide amides
FR2572399B1 (fr) * 1984-10-31 1987-01-16 Panmedica Sa Nouveaux derives de l'adamantanamine, leurs procedes de preparation et medicaments les contenant
NO170884C (no) * 1986-08-18 1992-12-23 Hoffmann La Roche Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrimidinderivater
JPH0717655B2 (ja) * 1987-05-27 1995-03-01 三共株式会社 経口用セフアロスポリン化合物

Also Published As

Publication number Publication date
EP0516851A4 (en) 1993-06-09
EP0668290B1 (de) 1998-11-11
EP0516851B1 (de) 1996-06-19
EP0668290A1 (de) 1995-08-23
CA2076849A1 (en) 1991-08-29
DK0668290T3 (da) 1999-07-26
DE69130489T2 (de) 1999-05-12
DE69120397T2 (de) 1996-11-07
WO1991013081A1 (fr) 1991-09-05
DE69120397D1 (de) 1996-07-25
DE69130489D1 (de) 1998-12-17
EP0516851A1 (de) 1992-12-09

Similar Documents

Publication Publication Date Title
DK583789A (da) System til transmucosal indgivelse af den aktive bestanddel af et laegemiddel
DK362189D0 (da) Farmaceutisk praeparat til intravenoes indgift
DK1155695T3 (da) Anvendelse af en 1,3-oxathiolannukleosid-analog til fremstillingen af et lægemiddel til specifik indgivelse
NO851170L (no) Lagringsstabile, hurtignedbrytende farmasoeytiske virksomme stoff-presslegemer
DK481989D0 (da) Farmaceutiske formuleringer
FI925778A (fi) Farmaceutiskt aktiva bensokinazolinfoereningar
DK0516851T3 (da) Fysiologisk aktiv substans, der er i stand til at gennemtrænge en biomembran
IT8224447A0 (it) Nuova sostanza ch-1fisiologicamente attiva eprocedimento per la sua produzione.
DK645788D0 (da) Anvendelse af ergolinderivater til fremstilling af et farmaceutisk praeparat
NL192304B (nl) Noötropisch geneesmiddel dat als werkzaam bestanddeel een pyroglutaminezuuramidederivaat bevat en een dergelijk pyroglutaminezuuramidederivaat.
IT8821271A0 (it) Derivati benzimidazolici farmacologicamente attivi.
NO883500L (no) Fremgangsmaate for fremstilling av et farmasoeytisk aktivt nitrometan.
DK79889A (da) Flerlagsplaster til transdermal laegemiddeladministration
NO892764D0 (no) Medikamentell administreringsform for droevtyggere.
TR24383A (tr) Konsantre yuezey aktif madde granuelleri yapmaya mahsus yoentem
IT8722501A0 (it) Formulazioni farmaceutiche per somministrazione transdermica.
DK559288D0 (da) Farmaceutisk praeparat for piperidinoalkanolderivater
DK640688A (da) Heterocyklisk substituerede imidater til anvendelse som insekticider
DK298389A (da) Farmaceutisk praeparat til topisk anvendelse omfattende et amin-funktionelt medikament
IT1237918B (it) Trascinatore per un asciugatore di biancheria con elettrodo di misura.
DE68908838D1 (de) Pharmazeutisch wirksame Dithioketen-Derivaten.
FI883738A0 (fi) Substituerade tienoimidazolderivat, foerfarande foer deras framstaellning, dessa innehaollande farmaceutiska produkter och deras anvaendning som magsyrasekret haemmande medel.
NO151323C (no) Analogifremgangsmaate til fremstilling av et terapeutisk aktivt n-(2-tienyl)-2-okso-2,3-dihydro-benzo(b)tiofen-3-karboksamid
IT8983425A0 (it) Supporto su rotelle perfezionato.
DK594789A (da) Farmaceutisk praeparat til systemisk, transdermal administration